Organization directory

Contacts:c/o MBC, Via Nizza, 52 - 10126 Torino Italy
Telephone: +39 0116706425
Fax: +39 0116706432
Contact person: Marco Malisani, Director
Field of business:Pharmaceutical
Keywords:PI3K, cystic fibrosis, lung inflammation.
Profile:Kither Biotech is a pharmaceutical product company that focuses its R&D activities on the development of new drugs. In the last decade, the incidence of chronic inflammation has grown rapidly. About one third of the population in industrialized countries suffers from chronic inflammatory diseases. Despite recent advances in prevention, diagnosis and treatment of such diseases, available therapies today remain largely unsatisfactory in terms of effectiveness and improvement of the quality of patients’ lives. Recent discoveries have driven a better understanding of the biological mechanisms underlying chronic inflammation. In particular, they have led to the identification of new drug targets that are waiting to be exploited in targeted therapies. Over the past years, Kither team members have reached significant scientific results focusing on PI3K enzymes, which are key enzymes in chronic inflammatory diseases. Kither is directing its R&D activities on generating new compounds for the treatment of these pathologies.
bioPmed:bioPmed core member
Patents:Open patents list on Espacenet
Publications:Open publications on Pubmed

« Back